NXTC · ISSUER CIK 1661059
NextCure, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 NextCure, Inc. insiders reported $1.7M of open-market purchases and $185K of sales on SEC Form 4. The largest buyer was ADAR1 Capital Management, LLC (10% Owner), with $1.7M.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$1.7MInsider buying
$185KInsider selling
+$1.5MNet open-market
Oct 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202619:36 | Oct 27, 2026from Oct 23, 2026 | NXTC | 10% Owner · +1 joint | P · Buy | $4.95 | +10,851 | 733,270 | +2% | +$54K | -41.2% | +31.9% |
| Aug 12, 202611:35 | Aug 10, 2026 | NXTC | Former 10% Owner · +5 joint | S · Sell | $6.16 | −30,000 | 308,636 | -9% | −$185K | ||
| Aug 3, 202617:53 | Jul 31, 2026from Jul 30, 2026 | NXTC | 10% Owner · +1 joint | P · Buy | $4.93 | +329,153 | 722,419 | +84% | +$1.6M | -54.0% | +32.2% |